Auricular point stimulation plus dexamethasone trials for Breast cancer

All Auricular point stimulation plus dexamethasone trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Auricular point stimulation plus dexamethasone for Breast cancer

• Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
  NCT07716176 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
  NCT07716189 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
  NCT07537699 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
  NCT07537673 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Auricular point stimulation plus dexamethasone for Breast cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.